IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v615y2023i7951d10.1038_s41586-023-05736-y.html
   My bibliography  Save this article

Autoimmunity in Down’s syndrome via cytokines, CD4 T cells and CD11c+ B cells

Author

Listed:
  • Louise Malle

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Roosheel S. Patel

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Marta Martin-Fernandez

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • O Jay Stewart

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Quentin Philippot

    (Necker Branch, INSERM U1163, Necker Hospital for Sick Children
    University of Paris, Imagine Institute)

  • Sofija Buta

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Ashley Richardson

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Vanessa Barcessat

    (Icahn School of Medicine at Mount Sinai)

  • Justin Taft

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Paul Bastard

    (Necker Branch, INSERM U1163, Necker Hospital for Sick Children
    University of Paris, Imagine Institute
    The Rockefeller University
    Assistance Publique-Hôpitaux de Paris (AP-HP))

  • Julie Samuels

    (Icahn School of Medicine at Mount Sinai)

  • Clotilde Mircher

    (Institut Jérôme Lejeune)

  • Anne-Sophie Rebillat

    (Institut Jérôme Lejeune)

  • Louise Maillebouis

    (Institut Jérôme Lejeune)

  • Marie Vilaire-Meunier

    (Institut Jérôme Lejeune)

  • Kevin Tuballes

    (Icahn School of Medicine at Mount Sinai)

  • Brad R. Rosenberg

    (Icahn School of Medicine at Mount Sinai)

  • Rebecca Trachtman

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Jean-Laurent Casanova

    (Necker Branch, INSERM U1163, Necker Hospital for Sick Children
    University of Paris, Imagine Institute
    The Rockefeller University
    Necker Hospital for Sick Children)

  • Luigi D. Notarangelo

    (National Institutes of Health)

  • Sacha Gnjatic

    (Icahn School of Medicine at Mount Sinai)

  • Douglas Bush

    (Icahn School of Medicine at Mount Sinai)

  • Dusan Bogunovic

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

Abstract

Down’s syndrome (DS) presents with a constellation of cardiac, neurocognitive and growth impairments. Individuals with DS are also prone to severe infections and autoimmunity including thyroiditis, type 1 diabetes, coeliac disease and alopecia areata1,2. Here, to investigate the mechanisms underlying autoimmune susceptibility, we mapped the soluble and cellular immune landscape of individuals with DS. We found a persistent elevation of up to 22 cytokines at steady state (at levels often exceeding those in patients with acute infection) and detected basal cellular activation: chronic IL-6 signalling in CD4 T cells and a high proportion of plasmablasts and CD11c+TbethighCD21low B cells (Tbet is also known as TBX21). This subset is known to be autoimmune-prone and displayed even greater autoreactive features in DS including receptors with fewer non-reference nucleotides and higher IGHV4-34 utilization. In vitro, incubation of naive B cells in the plasma of individuals with DS or with IL-6-activated T cells resulted in increased plasmablast differentiation compared with control plasma or unstimulated T cells, respectively. Finally, we detected 365 auto-antibodies in the plasma of individuals with DS, which targeted the gastrointestinal tract, the pancreas, the thyroid, the central nervous system, and the immune system itself. Together, these data point to an autoimmunity-prone state in DS, in which a steady-state cytokinopathy, hyperactivated CD4 T cells and ongoing B cell activation all contribute to a breach in immune tolerance. Our findings also open therapeutic paths, as we demonstrate that T cell activation is resolved not only with broad immunosuppressants such as Jak inhibitors, but also with the more tailored approach of IL-6 inhibition.

Suggested Citation

  • Louise Malle & Roosheel S. Patel & Marta Martin-Fernandez & O Jay Stewart & Quentin Philippot & Sofija Buta & Ashley Richardson & Vanessa Barcessat & Justin Taft & Paul Bastard & Julie Samuels & Cloti, 2023. "Autoimmunity in Down’s syndrome via cytokines, CD4 T cells and CD11c+ B cells," Nature, Nature, vol. 615(7951), pages 305-314, March.
  • Handle: RePEc:nat:nature:v:615:y:2023:i:7951:d:10.1038_s41586-023-05736-y
    DOI: 10.1038/s41586-023-05736-y
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-023-05736-y
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/s41586-023-05736-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:615:y:2023:i:7951:d:10.1038_s41586-023-05736-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.